Synthetic control arms in clinical trials: Making it happen
Posted:
Can combining #AI tech & #RWD hold the key to overcoming challenges in #clinicaltrial design?
Join Sensyne Health on 24th February 2:00 p.m. GMT as experts discuss the application of #SyntheticControlArms – a new way of approaching clinical trials.
Schizophrenia is a psychiatric disorder characterized by altered thinking and emotional patterns, hallucinations, false or irrational beliefs (i.e., delusions), cognitive deficits, and disorganized speech.
Bipolar disorder BD, on the other hand, is marked by extreme mood swings, ranging between periods of…
New joint research program combines UCSF’s advanced clinical and research teams with GE HealthCare’s technical and engineering expertise to develop solutions that directly impact patient care.
Read full article here.
Attendees
Sponsors and Exhibitors
Contact us